SMTL ID : 9bii.1

Mycobacterium tuberculosis EFPA antiparallel dimer

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

homo-dimer

Ligands

6 x 01: [(2~{R})-3-[[(2~{R})-2,3-bis(oxidanyl)propoxy]-oxidanyl-phosphoryl]oxy-2-hexadecanoyloxy-propyl] octadecanoate

01.1: 49 residues within 4Å: Chain A: Q.142, T.146, T.150, I.153, L.243, F.263, A.264, T.267, A.268, S.271, V.272, L.275, I.393, A.396, G.397, M.400, L.403, T.404, V.405, C.406, I.407, G.408, L.409, Y.410, Q.412, F.426, F.429, M.433, L.460, A.463, M.464, G.467, M.471, L.481, P.484, I.485, G.488, G.489, I.492, V.496, L.499, T.500, A.519, L.520, Q.523, Y.567, T.568, L.571 Ligands: 01.2 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:T.267, A:I.393, A:L.403, A:T.404, A:I.407, A:Y.410, A:Y.410, A:F.429, A:L.460, A:I.485, A:L.520 Hydrogen bonds: A:T.150, A:S.271, A:S.271 01.2: 31 residues within 4Å: Chain A: D.383, V.388, A.396, M.400, T.453, I.454, G.457, Y.458, L.460, F.461, I.492, A.495, V.496, L.499, A.578, I.579, I.580, V.581, G.582, G.583, M.584, L.586, F.587 Chain B: F.461, L.465, G.576, I.579, I.580 Ligands: 01.1, 01.5, Y01.8 5 PLIP interactions: 4 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:I.454, A:I.579, A:M.584, A:F.587, B:F.461 01.3: 25 residues within 4Å: Chain A: S.149, I.153, I.174, T.175, Y.177, V.178, F.181, G.182, M.185, A.329, C.330, A.333, V.334, F.337, S.338, A.357, A.361, F.401, V.405, M.521, S.524, L.525, P.528, L.529, L.531 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:A.333, A:V.334, A:F.337, A:F.337, A:F.337, A:A.361, A:L.525 01.4: 49 residues within 4Å: Chain B: Q.142, T.146, T.150, I.153, L.243, F.263, A.264, T.267, A.268, S.271, V.272, L.275, I.393, A.396, M.400, L.403, T.404, V.405, C.406, I.407, G.408, L.409, Y.410, Q.412, F.426, F.429, M.433, L.460, A.463, M.464, G.467, M.471, L.481, P.484, I.485, G.488, G.489, I.492, V.496, L.499, T.500, A.519, L.520, Q.523, Y.567, T.568, L.571 Ligands: 01.5, 01.6 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:L.403, B:T.404, B:Y.410, B:Y.410, B:F.429, B:L.460, B:I.485, B:L.520 Hydrogen bonds: B:S.271 01.5: 30 residues within 4Å: Chain A: F.461, L.465, G.576, I.579, I.580 Chain B: V.388, A.396, M.400, T.453, I.454, G.457, Y.458, L.460, F.461, I.492, A.495, V.496, L.499, A.578, I.579, I.580, V.581, G.582, G.583, M.584, L.586, F.587 Ligands: 01.2, 01.4, Y01.7 6 PLIP interactions: 5 interactions with chain B, 1 interactions with chain A Hydrophobic interactions: B:V.388, B:I.454, B:V.496, B:F.587, B:F.587, A:F.461 01.6: 25 residues within 4Å: Chain B: S.149, I.153, I.174, T.175, Y.177, V.178, F.181, G.182, M.185, A.329, C.330, A.333, V.334, F.337, S.338, A.357, A.361, F.401, V.405, M.521, S.524, L.525, P.528, L.529 Ligands: 01.4 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:V.178, B:A.333, B:V.334, B:F.337, B:F.337, B:F.337, B:L.525

2 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)

Y01.7: 13 residues within 4Å: Chain A: L.395, V.530, V.533, R.541, Y.569, L.572, W.573, G.576, A.577, I.580 Chain B: L.586, F.587 Ligands: 01.5 8 PLIP interactions: 6 interactions with chain A, 2 interactions with chain B Hydrophobic interactions: A:Y.569, A:L.572, A:L.572, A:W.573, A:W.573, A:A.577, B:L.586, B:F.587 Y01.8: 14 residues within 4Å: Chain A: R.450, L.586, F.587 Chain B: L.395, V.530, V.533, R.541, Y.569, L.572, W.573, G.576, A.577, I.580 Ligands: 01.2 5 PLIP interactions: 3 interactions with chain B, 2 interactions with chain A Hydrophobic interactions: B:Y.569, B:W.573, B:W.573, A:F.587, A:F.587

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Khandelwal, N.K. et al., Mycobacterium tuberculosis EFPA antiparallel dimer. To Be Published

Release Date

2025-02-05

Peptides

Uncharacterized MFS-type transporter EfpA: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Uncharacterized MFS-type transporter EfpA

Related Entries With Identical Sequence